Evidence map›Paper›PMID 28730323›Full record

ReviewClinical & experimental metastasis2017

The pathogenesis, diagnosis, and management of metastatic tumors to the ovary: a comprehensive review.

Ondřej Kubeček, Jan Laco, Jiří Špaček, Jiří Petera, Jindřich Kopecký, Alena Kubečková, Stanislav Filip

Abstract readReview
In one paragraph

Review in Clinical & experimental metastasis, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Isolated Unilateral Ovarian Metastasis from Breast Cancer Demonstrated byMolecular imaging and radionuclide therapy · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Pictorial review of bilateral adnexal lesions.Abdominal radiology (New York) · 2025
    Review
  16. Review
  17. Asian consensus on normothermic intraperitoneal and systemic treatment for gastric cancer with peritoneal metastasis.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2025
    Article
  18. Article
  19. Article
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ondřej KubečekDepartment of Oncology and Radiotherapy, Faculty of Medicine and University Hospital in Hradec Králové, Charles University, Sokolská 581, 500 05, Hradec Králové, Czech Republic. okubec@gmail.com.ORCID 0000-0003-2105-625X
Jan LacoThe Fingerland Department of Pathology, Faculty of Medicine and University Hospital in Hradec Králové, Charles University, Hradec Králové, Czech Republic.ORCID 0000-0002-9602-7501
Jiří ŠpačekDepartment of Obstetrics and Gynecology, Faculty of Medicine and University Hospital in Hradec Králové, Charles University, Hradec Králové, Czech Republic.ORCID 0000-0003-4887-3196
Jiří PeteraDepartment of Oncology and Radiotherapy, Faculty of Medicine and University Hospital in Hradec Králové, Charles University, Sokolská 581, 500 05, Hradec Králové, Czech Republic.
Jindřich KopeckýDepartment of Oncology and Radiotherapy, Faculty of Medicine and University Hospital in Hradec Králové, Charles University, Sokolská 581, 500 05, Hradec Králové, Czech Republic.ORCID 0000-0002-4126-0410
Alena KubečkováDepartment of Obstetrics and Gynecology, Faculty of Medicine and University Hospital in Hradec Králové, Charles University, Hradec Králové, Czech Republic.
Stanislav FilipDepartment of Oncology and Radiotherapy, Faculty of Medicine and University Hospital in Hradec Králové, Charles University, Sokolská 581, 500 05, Hradec Králové, Czech Republic.ORCID 0000-0002-8567-0745

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Secondary tumors of the ovary account for 10-25% of all ovarian malignancies. The most common tumors that give rise to ovarian metastases include breast, colorectal, endometrial, stomach, and appendix cancer. The correct diagnosis of secondary ovarian tumors may be challenging as they are not infrequently misdiagnosed as primary ovarian cancer, particularly in the case of mucinous adenocarcinomas. The distinction from the latter is essential, as it requires different treatment. Immunohistochemistry plays an important role in distinguishing primary ovarian tumors from extra-ovarian metastases and, furthermore, may suggest the primary tumor site. Despite extensive study, some cases remain equivocal even after assessing a broad spectrum of antigens. Therefore, gene expression profiling represents an approach able to further discriminate equivocal findings, and one that has been proven effective in determining the origin of cancer of unknown primary site. The available data concerning secondary ovarian tumors is rather limited owing to the relative heterogeneity of this group and the practical absence of any prospective trials. However, several intriguing questions are encountered in daily practice, including rational diagnostic workup, the role of cytoreductive surgery, and consequent adjuvant chemotherapy. This review seeks to address these issues comprehensively and summarize current knowledge on the epidemiology, pathogenesis, and management of secondary ovarian tumors, including further discussion on the different pathways of metastatisation, metastatic organotropism, and their possible molecular mechanisms.

Indexed as

Adenocarcinoma, MucinousCarcinogenesisFemaleHumansOvarian NeoplasmsKrukenberg tumorMetastasisNeoplasmOvarian cancerOvaryTumor

Identifiers

PMID28730323
PMCPMC5561159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.